Epstein-Barr virus-positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma

Br J Haematol. 2001 Feb;112(2):373-6. doi: 10.1046/j.1365-2141.2001.02579.x.

Abstract

We report on a patient with follicular non-Hodgkin's lymphoma (NHL) who developed a fatal high-grade Epstein-Barr virus (EBV)-positive NHL after conventional chemotherapies. The sudden onset of the high-grade lymphoma was accompanied by increasing circulating EBV genome copies and was complicated by spontaneous rupture of the spleen. Splenic tissue was diffusely infiltrated by large B cells. In situ hybridization for Epstein-Barr-encoded RNA (EBER) 1-2 was positive in 70% of cells, and molecular analysis revealed the presence of EBV DNA and a monoclonal IgH gene rearrangement. This case shows that the immunosuppression of multiple treatments may induce uncontrolled reactivation of a latent EBV infection, contributing to high-grade transformation in heavily treated lymphoma patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • DNA, Viral / analysis
  • Fatal Outcome
  • Gene Rearrangement
  • Herpesvirus 4, Human* / genetics
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunohistochemistry
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / virology*
  • Lymphoma, Follicular / complications
  • Lymphoma, Follicular / therapy*
  • Male
  • RNA, Viral / analysis
  • Rupture, Spontaneous
  • Splenic Rupture / complications
  • Virus Latency

Substances

  • DNA, Viral
  • Immunoglobulin Heavy Chains
  • RNA, Viral